Drugs / Cesium 131
Cesium 131
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02794675 | Dec 2016 → Jul 2020 | head and neck squamous cell carcinoma | Case Comprehensive Cancer Center | Completed | No outcome recorded |
| Phase 0 | NCT02467738 | Mar 2015 → May 2020 | head and neck carcinoma | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 2
| Date | Issuer | Release |
|---|---|---|
| 2023-10-05 | Perspective Therapeutics | Results Perspective Therapeutics’ Cesium-131 Featured at the American Society for Radiation Oncology’s Annual Conference perspectivetherapeutics.com ↗
The authors concluded that Cesium-131 brachytherapy is a promising alternative to pelvic exenteration, which can be a significant surgical procedure. |
| 2023-06-27 | Perspective Therapeutics | Results Perspective Therapeutics’ Cesium-131 Featured at the American Brachytherapy Society’s Annual Conference perspectivetherapeutics.com ↗
The authors reported that Cesium-131 prostate brachytherapy provided disease-free survival rates of 97.8% and 96%, at 5 and 10 years respectively. |
All press releases naming this drug 5 releases
| Date | Issuer | Release |
|---|---|---|
| 2023-10-05 | Perspective Therapeutics | Perspective Therapeutics’ Cesium-131 Featured at the American Society for Radiation Oncology’s Annual Conference perspectivetherapeutics.com ↗ |
| 2023-08-09 | Perspective Therapeutics | Perspective Therapeutics and GT Medical Technologies Collaborate to Expand Access to Unique Cesium-131 Based Brain Cancer Treatment perspectivetherapeutics.com ↗ |
| 2023-06-27 | Perspective Therapeutics | Perspective Therapeutics’ Cesium-131 Featured at the American Brachytherapy Society’s Annual Conference perspectivetherapeutics.com ↗ |
| 2023-06-16 | Perspective Therapeutics | Perspective Therapeutics’ Cesium-131 to be Featured in Presentations at the 2023 American Brachytherapy Society’s Annual Meeting perspectivetherapeutics.com ↗ |
| 2022-06-21 | Perspective Therapeutics | Isoray’s Cesium-131 Featured in Presentations at American Brachytherapy Society’s Annual Conference perspectivetherapeutics.com ↗ |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cesium 131 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02794675 ↗ |
| Known as | cesium Cs 131 | “Radioactive drugs, such as cesium Cs 131, may carry radiation directly to tumor cells” NCT02467738 ↗ |
| Known as | Cs-131 | “intraoperative Cesium-131 (Cs-131) brachytherapy” PMID 34900741 ↗ Nov 2021 |
| Modality | Other / unclassified | “Radioactive drugs, such as cesium Cs 131” NCT02467738 ↗ |
| Route | Other | “Permanently implanting cesium Cs 131 into the wound bed after surgery” NCT02467738 ↗ |